» Articles » PMID: 27173976

Randomized Trial Comparing Pulmonary Vein Isolation Using the SmartTouch Catheter with or Without Real-time Contact Force Data

Overview
Journal Heart Rhythm
Publisher Elsevier
Date 2016 May 14
PMID 27173976
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Contact force (CF) information may improve the safety and efficacy of ablation for paroxysmal atrial fibrillation (PAF).

Objective: The purpose of this study was to assess the impact of CF data on ablation for PAF.

Methods: Patients undergoing first-time PAF ablation were randomized at 7 UK centers to ablation with (CF-on) or without (CF-off) CF data available to the operator, using the same ablation catheter and mapping system. An ablation CF of 5-40g was targeted. Pulmonary vein (PV) reconnection was assessed with adenosine at 60 minutes. Follow-up for arrhythmia recurrence was for 1 year with 7-day Holter recordings at 6 and 12 months.

Results: One hundred seventeen patients were studied (59 CF-on, 58 CF-off). In the CF-on group, a reduction in acute PV reconnection rates (22% vs 32%, P = .03) but no significant difference in 1-year success rates off antiarrhythmic drugs (49% vs 52%, P = .9) was observed. There was no difference in major complication rates: 2 of 59 (3%) CF-on, 3 of 58 (5%) CF-off (P = .7). Procedural and fluoroscopy times were not significantly different (P>.5). Overall mean CFs per ablation were not different between groups (13.4 [9.1-19.6]g CF-on, 13.4 [7.4-22.4]g CF-off, P = .5), but a greater proportion of readings in the CF-on group were in the target range (80% vs 68%, P<.001).

Conclusion: This randomized multicenter study demonstrated that CF data availability was associated with reduced acute PV reconnection but not improved 1-year success rates, procedural and fluoroscopy times, or complication rates. There was a reduction in extremes of CF, above and below the study target range, suggesting greater CF control during ablation.

Citing Articles

High Power Short Duration Atrial Fibrillation Ablation: Long-Term Predictors of Success and Recurrence - A Multivariate Analysis.

Vassallo F, Cunha C, Corsino L, Serpa E, Simoes Jr A, Hespanhol D Arq Bras Cardiol. 2024; 121(12):e20230837.

PMID: 39699452 PMC: 11634315. DOI: 10.36660/abc.20230837.


Catheter Ablation of Persistent AF-Where are We Now?.

ONeill L, De Becker B, De Smet M, Francois C, Le Polain De Waroux J, Tavernier R Rev Cardiovasc Med. 2024; 24(12):339.

PMID: 39077091 PMC: 11262453. DOI: 10.31083/j.rcm2412339.


Very high-power and short-duration radiofrequency ablation for atrial fibrillation in a Latin American low-volume private center.

Keegan R, Garmendia F, Gregorietti F, Urruti R, Onetto L J Interv Card Electrophysiol. 2024; 67(6):1399-1406.

PMID: 38261105 DOI: 10.1007/s10840-024-01756-4.


Unipolar-voltage-based evaluation of left atrial tissue properties and ablation outcome in patients with atrial fibrillation.

Kamioka M, Makimoto H, Watanabe T, Watanabe H, Okuyama T, Kaneshiro T Europace. 2023; 25(9).

PMID: 37539865 PMC: 10422692. DOI: 10.1093/europace/euad240.


Cardioneuroablation Using Epicardial Pulsed Field Ablation for the Treatment of Atrial Fibrillation.

OBrien B, Reilly J, Coffey K, Gonzalez-Suarez A, Quinlan L, van Zyl M J Cardiovasc Dev Dis. 2023; 10(6).

PMID: 37367403 PMC: 10299113. DOI: 10.3390/jcdd10060238.